| |
Company
Roster
|
|
Total
Insiders : |
25 |
|
|
|
Total
Direct Shares :
|
8,706,112 |
|
|
Total
Indirect Shares :
|
56,099,621 |
| |
%
Held by Insiders:
|
5.65% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Francis Chris |
|
2026-01-02 |
25,000 |
2017-01-25 |
0 |
| Tan Aik Na |
|
2025-12-08 |
25,400 |
2024-08-12 |
0 |
| Corrigan Mark |
|
2025-12-08 |
28,815 |
2024-08-12 |
0 |
| Rawcliffe Adrian |
|
2025-11-13 |
12,700 |
2024-08-12 |
0 |
| Verdine Gregory L. |
|
2025-08-22 |
285,217 |
|
0 |
| Bolno Paul |
|
2025-08-22 |
121,000 |
|
0 |
| Henry Christian O |
|
2025-08-13 |
29,645 |
2024-08-12 |
0 |
| Wagner Heidi L |
|
2025-08-11 |
44,930 |
2024-08-12 |
0 |
| Takanashi Ken |
|
2025-08-11 |
5,729,003 |
|
0 |
| Vargeese Chandra |
|
2025-03-04 |
362,687 |
2017-01-25 |
0 |
| Moran Kyle |
|
2025-02-04 |
89,218 |
|
0 |
| Shah Rajeev M. |
Director, 10% Owner |
2022-06-16 |
0 |
2025-11-13 |
18,231,824 |
| Panzara Michael A. |
See Remarks |
2022-02-16 |
75,817 |
2016-07-11 |
0 |
| Gaiero David G |
Interim CFO |
2020-02-03 |
6,392 |
|
0 |
| Baldry Mark |
Chief Commerical Officer |
2019-08-05 |
39,000 |
2019-08-05 |
0 |
| Regnante Keith |
Chief Financial Officer |
2019-03-07 |
29,186 |
2017-01-25 |
0 |
| Kolchinsky Peter |
Director, 10% Owner |
2017-11-13 |
0 |
2019-01-24 |
7,775,207 |
| Guerciolini Roberto |
See Remarks |
2016-12-07 |
4,000 |
2016-07-28 |
0 |
| Shin Nippon Biomedical Laboratories, Ltd. |
10% Owner |
2015-11-10 |
1,697,467 |
2015-11-16 |
1,984,130 |
| Wada Takeshi |
Director |
2015-11-10 |
100,635 |
|
0 |
| Miura Koji |
|
|
0 |
|
0 |
| Ra Capital Biotech Fund Lp |
Director, 10% Owner |
|
0 |
2015-11-16 |
7,088,651 |
| Glaxosmithkline Plc |
10% Owner |
|
0 |
2025-12-11 |
18,245,691 |
| Tanaka Masaharu |
|
|
0 |
|
0 |
| Kagoshima Shinsangyo Sousei Investment Limited Par |
10% Owner |
|
0 |
2017-09-18 |
2,774,118 |
|
0.28 (1.85%) 
